开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09939 开拓药业-B

交易中 04-08 15:26:57

2.700

+0.060

+2.27%

最高2.770	最低2.650	成交量299.15万
今开2.750	昨收2.640	日振幅4.55%
总市值13.47亿	流通市值13.47亿	总股本4.99亿
成交额814.89万	换手率0.60%	流通股本4.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09939","market":"HK","secType":"STK","nameCN":"开拓药业-B","latestPrice":2.7,"timestamp":1775633109589,"preClose":2.64,"halted":0,"volume":2991500,"delay":0,"changeRate":0.022727272727272745,"floatShares":499000000,"shares":499000000,"eps":-0.5103639870340357,"marketStatus":"交易中","change":0.06,"latestTime":"04-08 15:26:57","open":2.75,"high":2.77,"low":2.65,"amount":8148885,"amplitude":0.045455,"askPrice":2.71,"askSize":80500,"bidPrice":2.7,"bidSize":101500,"shortable":0,"etf":0,"ttmEps":-0.5093246893571043,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1775635800000},"marketStatusCode":2,"adr":0,"listingDate":1590076800000,"exchange":"SEHK","adjPreClose":2.64,"openAndCloseTimeList":[[1775611800000,1775620800000],[1775624400000,1775635200000]],"volumeRatio":0.842686,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09939","defaultTab":"news","newsList":[{"id":"2625844389","title":"广东省药监局：广州合和医药不符合药品GMP要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2625844389","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625844389?lang=zh_cn&edition=full","pubTime":"2026-04-07 13:22","pubTimestamp":1775539349,"startTime":"0","endTime":"0","summary":"蓝鲸新闻4月7日讯，广东省药品监督管理局于2026年3月31日发布2026年第28号通告，通报近期对省内药品委托生产企业的监督检查情况。本次检查覆盖26家药品上市许可持有人及受托生产企业，涉及委托生产质量管理、工艺合规性、质量协议履行等关键环节。检查发现，25家企业符合要求，广州合和医药有限公司因存在不符合药品GMP的情形被判定为“不符合要求”。监管部门已责令该企业暂停相关风险产品的生产与销售，并采取相应风险控制措施。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775538677304537936","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1515","159938","BK1161","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625854819","title":"A股三大股指集体上涨，石油化工爆发，消费电子、存储器拉升，医药股调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2625854819","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625854819?lang=zh_cn&edition=full","pubTime":"2026-04-07 10:07","pubTimestamp":1775527643,"startTime":"0","endTime":"0","summary":"早盘存储芯片概念震荡反弹 ，同有科技涨超10%，佰维存储、德明利、伟测科技、普冉股份等跟涨。消费电子概念开盘活跃，折叠屏方向领涨，福蓉科技一字涨停，宜安科技涨超9%，智动力、精研科技、联得装备、安洁科技、大富科技等多股高开。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3769354","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159982","BK1515","159938","BK1161","159732","09939","399300","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625564605","title":"股市必读：欧康医药（920230）登4月3日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2625564605","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625564605?lang=zh_cn&edition=full","pubTime":"2026-04-07 02:13","pubTimestamp":1775499190,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，欧康医药报收于14.45元，下跌1.1%，换手率35.11%，成交量16.59万手，成交额2.59亿元。当日关注点来自交易信息汇总：4月3日欧康医药主力资金净流入1204.85万元，占总成交额4.66%。来自交易信息汇总：欧康医药因当日换手率达20%于4月3日登上龙虎榜，系近5个交易日内第2次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1515","09939","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624591276","title":"4月3日欧康医药（920230）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2624591276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624591276?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:42","pubTimestamp":1775209365,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月3日公布的交易公开信息显示，欧康医药因当日换手率达到20%的前5只股票登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年4月3日收盘，欧康医药报收于14.45元，下跌1.1%，换手率35.11%，成交量16.59万手，成交额2.59亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624183655","title":"4月3日东诚药业跌5.63%，银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624183655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624183655?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:15","pubTimestamp":1775204103,"startTime":"0","endTime":"0","summary":"证券之星消息，4月3日东诚药业跌5.63%，收盘报14.58元，换手率6.08%，成交量45.22万手，成交额6.66亿元。重仓东诚药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为银河基金的银河医药混合A。银河医药混合A目前规模为4.29亿元，最新净值0.6285，较上一交易日下跌0.03%，近一年上涨18.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300031235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","002675","159938","BK1574","09939","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624653385","title":"长春高新：医药创新高投入、长周期、慢回报是行业基本规律","url":"https://stock-news.laohu8.com/highlight/detail?id=2624653385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624653385?lang=zh_cn&edition=full","pubTime":"2026-04-03 15:27","pubTimestamp":1775201228,"startTime":"0","endTime":"0","summary":"证券之星消息，长春高新04月03日在投资者关系平台上答复投资者关心的问题。正如之前多次回复您提问中提到的费用投入和第二曲线等情况，医药创新高投入、长周期、慢回报是行业基本规律，转型投入与短期营收不匹配并非低效，而是正常阶段特征。公司坚持可控投入、精准培育，希望能够尽快拓展新的增长曲线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300024484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0057","159938","BK0028","BK1515","BK1161","BK0239","BK0075","BK0046","BK1574","000661","09939","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624329636","title":"特朗普医药新政靴子落地：对部分进口药开征 100% 关税，供应链风险恐加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2624329636","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624329636?lang=zh_cn&edition=full","pubTime":"2026-04-03 08:30","pubTimestamp":1775176200,"startTime":"0","endTime":"0","summary":"智通财经APP注意到，特朗普政府将对某些进口药品征收高达100%的关税，尽管设有几项重大豁免。声明称，对于与白宫达成协议的主要经济体，其进口产品的关税上限将被设定为15%。该条款允许总统单方面对被视为威胁国家安全的进口产品征收关税。特朗普周四还采取行动，简化并收紧了金属关税。特朗普长期以来一直批评海外药品生产威胁国家安全，并曾提出征收高达200%关税的设想以鼓励国内制造。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","159938","BK1161","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624633302","title":"新股消息 | 汇伦医药递表港交所主板","url":"https://stock-news.laohu8.com/highlight/detail?id=2624633302","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624633302?lang=zh_cn&edition=full","pubTime":"2026-04-03 07:20","pubTimestamp":1775172014,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所4月2日披露，上海汇伦医药股份有限公司向港交所主板提交上市申请书，中信证券为独家保荐人。招股书显示，汇伦医药是一家在药品开发及商业化方面拥有良好过往业绩的制药公司。在此基础上，公司正积极拓展能力，并以针对重大疾病及危重症的创新药物作为战略重点。同时，公司的创新药物管线已取得稳步进展，包括四款I类创新药物及三款II类改良新药目前处于临床开发阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","HEXmain","159938","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624577130","title":"4月2日欧康医药（920230）龙虎榜数据：机构净卖出348.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624577130","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624577130?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:42","pubTimestamp":1775122960,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月2日公布的交易公开信息显示，欧康医药因当日收盘价涨幅达到20%的前5只股票登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年4月2日收盘，欧康医药报收于14.61元，上涨29.98%，换手率25.1%，成交量11.86万手，成交额1.66亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出348.1万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200032524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK1161","159938","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624520491","title":"医药、医疗产业链持续走强 济民健康等多股涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2624520491","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624520491?lang=zh_cn&edition=full","pubTime":"2026-04-02 13:42","pubTimestamp":1775108520,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月2日，午后医药产业链持续走强，医药商业等细分展开补涨，济民健康、合富中国涨停，此前津药药业、益佰制药、北大医药涨停，华人健康、百洋医药、漱玉平民、建发致新、人民同泰等多股涨超5%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-02/doc-inhtavkf9449505.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-02/doc-inhtavkf9449505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0251","BK1161","BK0201","603222","BK1515","159891","09939","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624852685","title":"市场再迎修复反弹，医药板块持续爆发，算力链卷土重来","url":"https://stock-news.laohu8.com/highlight/detail?id=2624852685","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624852685?lang=zh_cn&edition=full","pubTime":"2026-04-02 09:24","pubTimestamp":1775093066,"startTime":"0","endTime":"0","summary":"另一方面，相较于高位的AI板块，医药板块具备明显的“低位洼地”优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/zldongxiang/20260402/32120260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1515","159938","BK1161","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624452552","title":"当医药重回舞台中央","url":"https://stock-news.laohu8.com/highlight/detail?id=2624452552","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624452552?lang=zh_cn&edition=full","pubTime":"2026-04-02 09:06","pubTimestamp":1775091960,"startTime":"0","endTime":"0","summary":"　　最近财报密集披露期，有好多话题想分享，由于需要大量的阅读财报和听电话会议，耽搁了一些，但市场行情不等人，医药行业出现连续的大涨，行业短期关注度快速提升，医药又回到舞台中央。　　年初已经给大家明确了我们今年看好的方向《医药行业2026，继往开来》，这里来更新下创新药、CXO、器械出海一季度的表现，以强调我们看好的方向和资产。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-04-02/doc-inhtakui4381875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1574","09939","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624408215","title":"百利天恒一持股5%以上股东完成减持计划；博瑞医药实控人提名女儿为董事｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2624408215","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624408215?lang=zh_cn&edition=full","pubTime":"2026-04-02 07:00","pubTimestamp":1775084407,"startTime":"0","endTime":"0","summary":"｜2026年4月2日星期四｜NO.1百利天恒持股5%以上股东OAPIII（HK）Limited减持股份计划完成4月1日，百利天恒公告，因自身资金需求，OAPIII（HK）Limited拟通过集中竞价方式减持公司股份不超过4128738股，减持比例不超过公司总股本的1.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604023692459372.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604023692459372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159938","688506","09939","688166","BK1574","02615","91194","BK1515","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624513671","title":"兴业控股(00132)终止收购呼研所医药科技(广州)51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624513671","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624513671?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:03","pubTimestamp":1775045003,"startTime":"0","endTime":"0","summary":"智通财经APP讯，兴业控股(00132)发布公告，内容有关公司附属广东中创兴科资产管理有限公司拟以总代价5443.53万元收购呼研所医药科技(广州)51%股权。根据股权转让协议，由于首次支付代价的条件(包括约定的完成前资产剥离及债务清偿)未于股权转让协议签署之日起12个月届满时获满足，各方已于2026年4月1日确认，股权转让协议已根据其条款予以终止。为免疑义，董事会认为，股权转让协议的终止不会对集团的业务营运及财务状况产生任何重大不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK1164","BK1515","09939","159938","00132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624254599","title":"中国银河证券：战略定位升级推动医药高质量发展 推荐关注创新药、医疗AI等方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2624254599","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624254599?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:50","pubTimestamp":1775033439,"startTime":"0","endTime":"0","summary":"关注医药消费复苏及独立第三方ICL。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260401/20260401154556_67489.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260401/20260401154556_67489.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","09939","BK1147","BK0276","161027","BK1515","BK1564","601881","BK1574","06881","159992","150261","06978","159938","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122102127","title":"开拓药业-B2026年3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1122102127","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122102127?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:48","pubTimestamp":1775033311,"startTime":"0","endTime":"0","summary":"开拓药业-B（股票代码：09939）于2026年4月1日披露的股份变动月报表显示，截至2026年3月31日，公司注册股本及已发行股本均保持不变。\n公司月报显示，注册股本总额维持700,000,000股普通股，面值每股0.0001美元，总额70,000美元。截至本报告期末，已发行普通股数为498,660,100股，未出现新增发行、购回或注销行为，公司库存股数也为零。\n公告同时确认，公司在本月遵守香港联交所《上市规则》及相关法律规定，未发生任何股份期权、权证、可换股票据及其他协议或安排导致的股份变动。\n本月报由公司主席、执行董事及行政总裁童友之签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624953335","title":"4月1日常山药业涨5.72%，医药LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624953335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624953335?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:16","pubTimestamp":1775031400,"startTime":"0","endTime":"0","summary":"证券之星消息，4月1日常山药业涨5.72%，收盘报39.52元，换手率3.53%，成交量32.43万手，成交额12.71亿元。重仓常山药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为国泰基金的医药LOF。医药LOF目前规模为6.54亿元，最新净值0.5478，较上一交易日下跌0.27%，近一年上涨1.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK0239","300255","BK1574","BK1515","159938","BK0172","BK0070","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624935585","title":"A股反弹，医药股爆发，迎来四大催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2624935585","media":"中证金牛座","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624935585?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:21","pubTimestamp":1775028060,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　4月首个交易日，亚太股市集体大涨，A股反弹。截至收盘，上证指数上涨1.46%，深证成指上涨1.7%，创业板指上涨1.96%。　　医药、科技、消费等板块今天集体上涨，医药股表现最强，医疗服务、CRO、创新药等板块大涨。　　首先，最近市场受中东地缘冲突影响，波动较大，而医药股前期调整充分，因此受到避险资金的关注。　　最后，医药行业即将迎来两大重磅会议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-04-01/doc-inhsysky1761864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399300","159938","09939","159982","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624561686","title":"淘气天尊：昨天低吸不敢，今天普涨追高？醒醒！","url":"https://stock-news.laohu8.com/highlight/detail?id=2624561686","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624561686?lang=zh_cn&edition=full","pubTime":"2026-04-01 13:09","pubTimestamp":1775020149,"startTime":"0","endTime":"0","summary":"周三上午市场呈现高开震荡的普涨格局，投资者可以看到，早盘沪指高开47点于3939点，创业板高开70点于3255点，两市5158股上涨，239股下跌，开盘以后市场红盘强势震荡，沪指最高3952点、最低仅3929点，上午反压区域强势震荡，各大指数盘尾略微回落，但仍然不同程度收涨！最终沪指收涨52点于3944点，创业板收涨37点于3222点！那么对于这种行情，投资者该如何看待和解读？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangjuejin/20260401/32117934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000001.SH","510880","BK1515","000905.SH","515890","159967","BK1574","159982","BK1161","000300.SH","000688.SH","399006","512510","09939","399001","510300","512880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624156615","title":"港股异动 | 同源康医药-B(02410)涨超7% 年度研发成本约2.44亿元 将于AACR年会展示五项创新药研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2624156615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624156615?lang=zh_cn&edition=full","pubTime":"2026-04-01 11:58","pubTimestamp":1775015895,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B涨超7%，截至发稿，涨7.07%，报10.9港元，成交额3053.72万港元。消息面上，3月31日，同源康医药-B发布截至2025年12月31日止年度业绩，研发成本约2.44亿元，同比增加3.7%；其他收入及收益3760.9万元，同比增加23.14%。本届AACR年会将于2026年4月17日至22日在美国圣地亚哥举行，本公司参会壁报将分别于4月19日至4月21日展示。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","06978","02410","BK1161","BK4585","159992","BK4588","BK1574","BK1515","09939","VXUS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kintor.com.cn","stockEarnings":[{"period":"1week","weight":-0.0469},{"period":"1month","weight":0.0909},{"period":"3month","weight":0.2941},{"period":"6month","weight":0.056},{"period":"1year","weight":0.9412},{"period":"ytd","weight":0.3469}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"开拓药业有限公司是一家主要从事创新药产品研发的投资控股公司。该公司产品致力于解决未满足临床需求的疾病领域，管线主要涵盖皮科（如脱发、痤疮等）及肿瘤适应症。该公司在皮科领域有两款核心药物KX-826及GT20029。该公司在其他疾病领域包括转移性去势抗性前列腺癌（mCRPC）、肝癌、特发性肺纤维化、恶性血液疾病及多种实体瘤等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.020286},{"month":2,"riseRate":0.666667,"avgChangeRate":0.174983},{"month":3,"riseRate":0.333333,"avgChangeRate":0.058562},{"month":4,"riseRate":0.666667,"avgChangeRate":0.360972},{"month":5,"riseRate":0.6,"avgChangeRate":0.045244},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.066873},{"month":7,"riseRate":0.666667,"avgChangeRate":0.132768},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.071497},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.129033},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.103242},{"month":11,"riseRate":0.666667,"avgChangeRate":0.073526},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.185801}],"exchange":"SEHK","name":"开拓药业-B","nameEN":"KINTOR PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开拓药业-B,09939,开拓药业-B股票,开拓药业-B股票老虎,开拓药业-B股票老虎国际,开拓药业-B行情,开拓药业-B股票行情,开拓药业-B股价,开拓药业-B股市,开拓药业-B股票价格,开拓药业-B股票交易,开拓药业-B股票购买,开拓药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开拓药业-B(09939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开拓药业-B(09939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}